AstraZeneca vaccine: 79% effective and no rare blood clots in US trial
Enlarge / Vials of the AstraZeneca COVID-19 vaccine are seen during the opening of a vaccination center in Cyprus, on March 22, 2021.
Covid-19 Coverage
View more stories
Exceeding!-->…